Advertisements

Dextromethorphan/Guaifenesin Elixir

Quick links to important sections

Dextromethorphan/Guaifenesin Elixir

Advertisements
Advertisements

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Dextromethorphan/Guaifenesin Elixir

Quick Facts

Property Description
Active ingredient Dextromethorphan and Guaifenesin
Form Elixir / Oral solution
Pharmacological class Antitussive and Expectorant
General purpose Symptomatic relief for cough and chest congestion
Origin Synthetic and synthetic/naturally-derived

What Type of Combination Medicine is Dextromethorphan/Guaifenesin Elixir?

Dextromethorphan/Guaifenesin Elixir is a combination pharmacological preparation, classified as an oral solution or elixir, integrating two distinct active ingredients for symptomatic relief of respiratory symptoms. This liquid medication is defined by its dual pharmacological class properties: it contains an antitussive (cough suppressant) and an expectorant (mucus thinner). This dual component structure allows the preparation to address two different dimensions of cough and cold discomfort simultaneously, a balanced approach for managing common cold symptoms.

Composition and Origin: Dextromethorphan and Guaifenesin

The elixir contains the active ingredients Dextromethorphan and Guaifenesin. Dextromethorphan is a synthetic compound that acts centrally to quiet the urge to cough. Guaifenesin is a mucoactive agent that functions as an expectorant to help manage the physical consistency of secretions. The final drug form is typically positioned as an Over-the-Counter (OTC) product and is often formulated with flavoring to enhance palatability for both pediatric patients and the general population. This combination therapy is a common formulation for popular brands, making it an accessible option for temporary respiratory relief.

General Purpose: Dual Action for Cough and Chest Congestion

The general purpose of this preparation is to provide comprehensive management of the cough reflex and the physical obstruction caused by mucus. The Dextromethorphan component works to reduce the frequency and intensity of coughing fits, which is useful in typical use scenarios like suppressing nighttime coughing. Guaifenesin acts to reduce the viscosity of respiratory secretions, which makes the mucus easier to clear. This combination therapy is specifically designed to provide dual symptomatic relief, aiming to suppress the irritating cough and actively promote the expectoration of phlegm associated with chest congestion.

Advertisements

What side effects are possible with Dextromethorphan/Guaifenesin Elixir?

Possible Side Effects and Safety Information

The safety profile for Dextromethorphan/Guaifenesin Elixir is officially documented by health authorities and is categorized by the frequency and physiological system affected.


Officially Documented Adverse Reactions

Adverse reactions are formally grouped into system-organ classes, primarily involving the Gastrointestinal disorders and Nervous system disorders.

Classification Examples of Officially Listed Adverse Reactions
Common Nausea, vomiting, diarrhea, dizziness, drowsiness, headache, insomnia, nervousness.
Rare Allergic skin reactions, rash, and urticaria (hives).

These frequency classifications are based on regulatory standards and communicate the estimated probability of these effects appearing in clinical use.


Serious Safety Considerations and Restrictions

Regulatory documents emphasize specific safety restrictions and the potential for serious adverse reactions, often associated with high exposure or specific drug interactions.

Contraindications and Interactions: The product is strictly contraindicated for individuals who are currently taking or have taken a Monoamine Oxidase Inhibitor (MAOI) within the preceding 14 days. This restriction is due to the documented, life-threatening risk of Serotonin Syndrome.

Population-Specific Notes: The use of this combination product is generally not recommended for children younger than 4 to 6 years for cough and cold symptoms, based on safety and efficacy data. Caution is also noted for patients with a history of certain underlying conditions, including severe hepatic impairment and chronic pulmonary diseases.

Exposure-Related Patterns: Official labeling states that the risk of certain Central Nervous System (CNS) effects (such as confusion or hallucinations) is dose-dependent, increasing with higher exposure levels of dextromethorphan. Additionally, the potential for abuse and misuse is a documented regulatory safety concern.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose involving Dextromethorphan/Guaifenesin Elixir is documented to present a risk profile derived from both active ingredients, with the most severe outcomes attributed to the Dextromethorphan component. Documented manifestations often include nausea, vomiting, dizziness, confusion, hallucinations, tremor, and tachycardia (rapid heart rate).

Severe Manifestations

The most severe and potentially life-threatening outcomes officially cited in regulatory documents involve the central nervous system, including respiratory depression, seizures, coma, and the risk of Serotonin Syndrome. Systemic complications like rhabdomyolysis and hyperthermia are also noted. Specific considerations include an increased risk for severe symptoms in very small children and in individuals identified as poor metabolizers of the CYP2D6 enzyme.

Emergency Actions

Regulatory instructions mandate immediate action in case of suspected overdose. It is required to seek professional help or contact a Poison Control Center right away. Urgent medical help is necessary when the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Treatment is described as symptomatic and supportive, and Naloxone can be used by medical professionals to counteract Dextromethorphan-induced respiratory and CNS depression.

Advertisements

Therapeutic Uses of Dextromethorphan/Guaifenesin Elixir

What Dextromethorphan/Guaifenesin Elixir Treats: Main Uses and Benefits

This combination product is considered relevant for easing symptoms that interfere with daily functioning, specifically by managing cough and loosening mucus in the context of inflammatory or irritative states.

The elixir is commonly used to help with acute respiratory symptoms, including irritating, non-productive cough and the discomfort of thick mucus buildup and chesty congestion. It may be part of symptomatic management in conditions presenting with acute episodes like the common cold or flu. The core purpose plays a role in managing these combined symptomatic domains.

“This formulation is used across domains where additional symptomatic support is needed to address both the bothersome urge to cough and the physical discomfort of chest congestion.”

This medication is applied in addressing challenging manifestations related to the cough reflex and airway obstruction, which provides supportive relief when symptoms intensify. This simultaneous action contributes to improved comfort during periods of heightened and combined symptoms, and may assist with reducing symptoms that become more disruptive during flare-ups, often by assisting with the maintenance of restful sleep.


Quick Fact: Symptom Management Focus

Symptom Domain Primary Therapeutic Benefit
Irritating Cough Contributes to easing the frequency and intensity of cough.
Chest Congestion Relevant for supporting the expectoration of thick mucus.

Regulatory References

  1. NIH DailyMed drug information
Advertisements

Eligibility and Restrictions for Use

Eligibility and Restrictions for Use

The use of Dextromethorphan/Guaifenesin Elixir is governed by population eligibility rules set forth in regulatory documents. The medication is generally designated for use in adults and children 12 years of age and older.

Absolute Contraindications

The medication must not be used by certain populations due to high risk, including patients with a known hypersensitivity or allergy to Dextromethorphan, Guaifenesin, or any other formulation ingredient. Use is strictly prohibited in individuals currently taking or who have stopped taking a Monoamine Oxidase Inhibitor (MAOI) within the last 14 days. Individuals with Phenylketonuria (PKU) must confirm the specific elixir formulation does not contain phenylalanine.

Age and Condition Limitations

Official guidelines advise that over-the-counter cough and cold combination products are not routinely recommended for use in children under 4 years of age due to insufficient data on safety and efficacy. Use in any minor under 12 years of age requires checking the specific product label, as some high-strength formulations are strictly prohibited below this threshold.

Conditional Use

Consultation with a health professional is necessary for patients with certain chronic conditions, such as a persistent cough associated with asthma or smoking, a cough producing excessive phlegm, or severe hepatic or renal impairment. Additionally, pregnant or breastfeeding women must ask a health professional before use.

Advertisements

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

This medication's interaction profile is based on the components dextromethorphan and guaifenesin, and is defined by several mandatory restrictions and cautionary use requirements documented in official regulatory labeling.

Contraindicated Combinations

Monoamine Oxidase Inhibitors (MAOIs)

Taking this product concurrently with an MAOI, or within 14 days of stopping an MAOI, is strictly contraindicated due to the risk of a serious, potentially fatal, drug interaction. This interaction is rooted in the increased serotonergic effect when dextromethorphan is combined with MAOIs.

Cautionary Combinations

Caution is required when co-administering this product with the following drug categories:

  • Central Nervous System (CNS) Depressants and Alcohol: Other substances or medicines that cause drowsiness, such as certain opioid pain or cough relievers, and alcohol, may increase the sedative effects of this product. Concurrent use should be limited or avoided.
  • Serotonergic Agents: Other drugs that increase serotonin activity, including specific antidepressants or supplements (e.g., St. John's wort), carry a risk of additive serotonergic effects and must be monitored closely.
  • CYP Enzyme Inhibitors: Since dextromethorphan is metabolized by specific cytochrome P450 enzymes, co-administration with strong inhibitors of these enzymes may increase the concentration of dextromethorphan in the body.
  • Other Dextromethorphan/Guaifenesin Products: Taking other cough and cold medicines containing either dextromethorphan or guaifenesin is restricted to prevent exceeding recommended limits and potential additive effects.

Other Documented Interactions

The guaifenesin component may interfere with specific laboratory tests for certain acids (e.g., 5-HIAA and VMA) in urine, potentially leading to false results. Healthcare providers and laboratory personnel must be informed of the use of this medication before testing.

Advertisements

Mechanism of Action

Central Modulation of the Cough Reflex Threshold

This domain explains how Dextromethorphan acts centrally on the Central Nervous System ( CNS). It modulates the key N-methyl-D-aspartate ( NMDA) and Sigma-1 (sigma1) receptors, which reduces the excitatory input to the medullary cough center. The resulting physiological effect is an elevated cough threshold, leading to reduced output of efferent cough signals.


Peripheral Reflexive Alteration of Secretion Viscosity

This domain covers the mucoactive mechanism of Guaifenesin. It functions via an indirect reflex: after absorption, it activates vagal afferent nerves in the gastrointestinal tract, signaling respiratory glands to increase fluid output. This leads to the physiological consequence of reduced viscosity and increased fluidity of tracheobronchial secretions, which results in increased mobility of the ciliary-moved layer.


Interaction between Central and Peripheral Mechanisms

The overall effect profile arises from the complementary interaction of the two independent mechanisms. Dextromethorphan exerts control over the neural drive to cough, while Guaifenesin modifies the rheological properties of secretions. This coordinated modulation affects both the CNS threshold and the physical state of tracheobronchial secretions.

Advertisements

Dosage and Administration Information

Administration Guidelines: How to Use the Elixir

This section describes the standardized instructions for taking Dextromethorphan/Guaifenesin oral solution.

Administration Scope Labeled Instruction
Route of Administration The preparation is administered via the oral route only, intended for ingestion.
Dosing Schedule Doses are to be taken every 4 hours as a standard regimen.
Dosing Limit Patients must not exceed 6 doses in any 24-hour period.
Timing with Meals Available labeling instructions do not specify restrictions; the medicine is generally taken without strict regard to food.

Procedural and Age-Group Rules

Procedural Conditions:

  • Measurement: The liquid dose must be measured using the dosing cup or accurate measuring device provided with the product to ensure correct volume delivery.
  • Temporary Use: The medication is intended for temporary administration to manage acute symptoms.

Age-Group Administration Rules:

Age Group Standard Dose Volume (Example)
Adults and Children 12 years and over 10 mL every 4 hours
Children 6 to under 12 years 5 mL every 4 hours
Children under 6 years Instructions specify to ask a doctor for use in this age group.

These instructions define the protocol for using the oral solution, establishing fixed 4-hour dosing intervals and strict maximum daily limits to control exposure to the active components. Compliance with the specified measurement device ensures the delivery of the intended volumes for each age group.

Advertisements

Recent Clinical Evidence

Dextromethorphan/Guaifenesin Elixir: Recent Clinical Evidence

Evidence for Use in Acute Cough and Chest Congestion

Available evidence includes short-term Randomized Controlled Trials (RCTs) which are used in research exploring how symptoms change over time. These studies focused on research contexts involving fluctuating symptoms, such as the episodic manifestations associated with the common cold or other upper respiratory tract infections. Researchers examined the components—Dextromethorphan (an antitussive) and Guaifenesin (an expectorant)—to evaluate outcomes related to physical discomfort stemming from respiratory symptoms.

Research so far indicates that results regarding symptom change were mixed and evidence is limited when considering the combination as a whole. Comparative evidence examining the fixed combination versus its components alone is often lacking. These findings help contextualize how patients reported their experience during periods of heightened symptom activity.


Types of Studies and Outcomes Examined

Available clinical evidence primarily comes from RCTs that compare the medicine to a placebo (an inactive substance). Trials measured specific axes of discomfort, including outcomes reflecting daily functioning or activity level. Researchers captured patient-reported outcomes describing perceived discomfort, such as sleep disturbance related to cough, and utilized objective metrics like cough counts. For the Guaifenesin component, studies measured outcomes related to the evaluation of thick, sticky mucus.


Follow-up Duration and Long-Term Data

Follow-up durations for the key studies were limited, with most research focusing on short-term symptom changes over a period typically not exceeding 10 days. Because the study designs were focused on temporary episodes, there is limited information for long-term outcomes or the durability of observed effects. Scientific reviews note that this gap means certainty remains low concerning how symptomatic observations were continued after the study period.


Research in Specific Populations and Gaps

Research was primarily conducted in Adults aged 16 years and older and in Young People (ages 12 to 16). Sample sizes were modest in many trials, which means results apply only to the populations studied. Data for very young children remains insufficient for use, which contributes to the low evidence grading often assigned by scientific review bodies. A key area of uncertainty lies in the conflicting and mixed findings reported, where scientific evaluations have noted that even observed changes, when present, appear to be small and may be of doubtful clinical relevance.

Key Studies & References

  1. Dextromethorphan and Guaifenesin - Oral Solution Drug Label Information (Symptomatic Uses and Therapeutic Classifications)
  2. Over-the-counter (OTC) medications for acute cough in children and adults in community settings (Systematic Review)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Dextromethorphan/Guaifenesin Elixir (FAQ)

Q: Does Dextromethorphan/Guaifenesin Elixir work to stop a dry cough or a wet cough?

This combination preparation contains two different components that address different types of cough discomfort. Dextromethorphan is described as relieving cough due to minor throat irritation, which is often associated with a dry cough. Guaifenesin is described as an expectorant that loosens phlegm and thins bronchial secretions, which is intended to help with chest congestion or a wet cough.

Q: How long does the effect of Dextromethorphan/Guaifenesin Elixir usually last?

The official dosing schedule for the medication is typically listed on the label as a dose to be taken every four hours. This recommended dosing interval often guides the general expectation of how long the effects of the combination product are anticipated to last.

Q: Is it normal to feel a little bit drowsy after taking the elixir?

Regulatory safety information lists drowsiness as a common side effect associated with the use of this medication. This classification indicates that the effect may be frequently experienced by some users.

Q: Does the elixir contain alcohol?

Official labeling for some product formulations specifies that the inactive ingredients are 'Alcohol Free.' The inactive ingredients list on the specific product label provides information regarding the alcohol content of the formulation being used.

Q: What are the most common stomach-related side effects reported?

Officially documented common side effects in the gastrointestinal system include nausea, vomiting, diarrhea, and stomach discomfort. These reactions are based on regulatory standards for estimated frequency of occurrence in clinical use.

Q: Is it true that this cough medicine can cause hallucinations in large amounts?

Official regulatory safety notes state that the risk of certain Central Nervous System (CNS) effects, such as confusion or hallucinations, is described as being dose-dependent. This means the risk is noted to increase with higher levels of exposure.

Q: Does this medicine interact with common pain relievers like Tylenol (acetaminophen)?

Many cough and cold remedies contain acetaminophen. Regulatory guidance addresses the need to check all product labels to ensure recommended daily limits of acetaminophen are not exceeded when combining medicines.

Q: Can I take Dextromethorphan/Guaifenesin Elixir if I am already taking medication for depression (an SSRI)?

Taking this product concurrently with selective serotonin reuptake inhibitors (SSRIs) or other serotonergic agents is a cautionary combination. This combination can increase the risk of a serious adverse reaction called Serotonin Syndrome, which is why official warnings are in place.

Q: Can this medicine be taken by people who have diabetes?

Official labels indicate that patients with diabetes are advised to obtain professional guidance before using the medicine. This caution is often related to the inactive ingredients, such as sugars or sweeteners, that may be present in the liquid formulation.

Q: Is the red dye or color in the elixir a common allergen?

The specific product label lists all inactive ingredients, which can include color additives like FD&C Red No. 40. The full ingredients list, including non-active components, is available on the product label for individuals to review.

Q: What should I know about taking this product if I have high blood pressure?

The Dextromethorphan/Guaifenesin combination alone does not possess sympathomimetic properties, meaning it does not typically raise blood pressure. However, official warnings advise that patients with high blood pressure should be cautious about combination products that include decongestants (like phenylephrine or pseudoephedrine), which can affect blood pressure.

Q: Does taking this medicine make me tired or dizzy?

Dizziness and drowsiness are both listed as common side effects associated with this medication according to regulatory documents. Drowsiness can be described as feeling tired or sleepy.

Q: Is it possible to develop a tolerance to Dextromethorphan over time?

Regulatory attention has addressed the potential for misuse of Dextromethorphan. Some international agencies have mandated the removal of claims suggesting 'no tolerance or addiction with long-term use' from product instructions.

Q: Is this elixir considered a narcotic or a controlled substance?

Federally, Dextromethorphan/Guaifenesin Elixir is generally classified as an Over-the-Counter (OTC) product. Dextromethorphan is a non-opiate antitussive.

Q: What are the signs of taking too much of this medicine?

Official regulatory labels state that in the event of a suspected overdose, contacting a Poison Control Center or seeking medical help right away is necessary. They do not list specific symptoms on the over-the-counter labels but stress the immediate need for professional help.

Q: Are there any non-drug products (like herbal supplements) that should be avoided while using this elixir?

Specific herbal supplements, such as St. John's wort, are noted in regulatory information. This supplement is listed for its potential to increase serotonin activity, and therefore should be monitored due to the risk of interaction with Dextromethorphan.

Q: Is it safe to drive or operate machinery after taking this cough syrup?

Official warnings state that the medication may affect coordination, reaction time, or judgment. Because the medication may affect coordination, reaction time, or judgment, users are guided to determine its individual effects before engaging in tasks that require full attention.

Q: Can this product be used by someone who is breastfeeding?

Official regulatory labels indicate that pregnant or breastfeeding women should obtain guidance from a health professional prior to use. This general caution is provided on all labels.

Q: What is the difference between Dextromethorphan/Guaifenesin Elixir and products with codeine?

Dextromethorphan is classified as a non-opiate cough suppressant that works by acting on the cough center in the brain. In contrast, codeine is an opiate agonist that acts on the cough center and is associated with a different set of risks, including respiratory depression and dependency potential.

Q: What does the research evidence generally say about the effectiveness of Guaifenesin for loosening mucus?

Guaifenesin is scientifically classified as a mucoactive agent. Its role, based on official guidance, is to increase the hydration and decrease the viscosity of mucus to improve the clearance of accumulated secretions.

Q: Why is the Guaifenesin component called an expectorant?

Guaifenesin is called an expectorant because of its official pharmacological definition. An expectorant is a drug or agent that acts to loosen and thin sputum and bronchial secretions to ease their expectoration (the clearing of phlegm from the chest).

Q: Is there a link between Dextromethorphan and feelings of anxiety or nervousness?

Nervousness is listed as a common side effect in the official safety profile. Regulatory information also indicates that high-dose exposure or interactions with certain drugs may increase the risk of anxiety.

Q: Does Dextromethorphan/Guaifenesin Elixir help with nasal congestion?

The official purpose of the Dextromethorphan and Guaifenesin combination product is to relieve cough and loosen chest congestion. This combination is not indicated to treat nasal congestion.

Q: What should a patient do if they develop a rash after taking the elixir?

Official instructions state that if a rash occurs, discontinuing the product is required, and professional medical guidance should be sought. This instruction also applies if the cough lasts more than 7 days, returns, or is accompanied by fever or persistent headache.

Q: Is the medication designed to suppress the cough reflex completely?

Dextromethorphan is classified as a cough suppressant that works by calming the cough reflex and raising the cough threshold. It is not designed to eliminate the reflex completely, but rather to reduce its frequency and intensity.

Q: Can this cough medicine cause high blood pressure?

High blood pressure is not listed as a common side effect for the Dextromethorphan/Guaifenesin combination at recommended doses. However, it can be a sign of an overdose or of a severe interaction with certain contraindicated medications (such as MAOIs).

Q: What are the reasons someone with a chronic obstructive pulmonary disease (COPD) diagnosis might be advised caution?

Official warnings advise patients with a chronic cough, such as that occurring with chronic pulmonary diseases, to consult a health professional before use. This is because the underlying condition may require specialized management beyond over-the-counter cough relief.

Q: Is it possible for the medicine to make my mucus thicker instead of thinner?

No, Guaifenesin is officially defined as an expectorant that acts to increase the fluidity and decrease the viscosity of tracheobronchial secretions. Its intended effect is to help thin the mucus.

Q: Are there any documented cases of addiction or dependency related to the cough suppressant component?

Abuse and misuse of the cough suppressant component are documented regulatory safety concerns. Case reports have described psychological and physical dependency, which is primarily associated with high-dose, non-therapeutic abuse.

Q: What are the general rules regarding combining this product with other cough and cold products?

Caution is strictly required when combining this elixir with other products to prevent exceeding recommended limits and potential additive effects. This is especially important when other medicines contain either Dextromethorphan or Guaifenesin.

Advertisements

How should Dextromethorphan/Guaifenesin Elixir be stored and disposed of?

How to Store and Dispose of Dextromethorphan/Guaifenesin Elixir

Storage of Dextromethorphan/Guaifenesin Elixir must strictly adhere to regulatory requirements to ensure product quality. The liquid must be maintained at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F). It must be kept tightly closed in its original container and protected from light and moisture; the official label advises that the elixir must not be frozen. For safety, the product must always be stored out of the reach and sight of children.


Disposal of unused or expired elixir should prioritize an official drug take-back program. If a program is unavailable, follow the official guidance for household disposal, which involves mixing the medicine with an undesirable substance and placing the sealed mixture in the trash. Do not flush the elixir unless specifically instructed by the regulatory label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Dextromethorphan/Guaifenesin Elixir found in:

A-Z Index: